MORRISVILLE, N.C., Nov. 22, 2017 -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Nathan Stasko, PhD, President and Chief Scientific Officer of Novan, is scheduled to participate in a fireside chat at the Piper Jaffray 29th Annual Healthcare Conference, Wednesday, Nov. 29, 2017, 12:00 p.m. EST, in New York.
The presentation will be webcast live and can be accessed through the Investor Relations section of the Company's website at www.Novan.com. An archived version of the webcast will be available approximately two hours following the live presentation for 30 days.
About Novan
Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. We believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.
CONTACT:
(Investors)
Novan, Inc.
investors@novan.com
(Media)
Cari Green
Director, Corporate Communications and Administration
cgreen@novan.com